Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Lymphoma, Follicular 1Depression 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Citalopram × Clear all
NCT05063604 2022-07-05

CAMAD

Hospital Universitari de Bellvitge

Phase 2 Terminated
40 enrolled
Breast

Breast Neoplasms

NCT00774813 2008-10-17

Nexalin Therapy for the Treatment of Depressive Symptoms

Kalaco Scientific, Inc.

Phase 2 Completed
120 enrolled
Lymphoid

Anxiety Disorders, Depression, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡